Get the Stockscreener App
5.28
0.75%
-0.04
After Hours:
5.20
-0.08
-1.52%
Journey Medical Corp stock is traded at $5.28, with a volume of 209.84K.
It is down -0.75% in the last 24 hours and down -19.14% over the past month.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
See More
Previous Close:
$5.32
Open:
$5.38
24h Volume:
209.84K
Relative Volume:
2.48
Market Cap:
$109.44M
Revenue:
$79.89M
Net Income/Loss:
$-12.35M
P/E Ratio:
-2.40
EPS:
-2.2
Net Cash Flow:
$32.92M
1W Performance:
-8.01%
1M Performance:
-19.14%
6M Performance:
+43.09%
1Y Performance:
+53.04%
1-Day Range:
$5.15
$5.515
1-Week Range:
$5.00
$6.335
52-Week Range:
$2.85
$8.11
Journey Medical Corp Stock (DERM) Company Profile
Name
Journey Medical Corp
Sector
Phone
480-434-6670
Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-28-24 | Resumed | ROTH MKM | Buy |
| Dec-07-21 | Initiated | B. Riley Securities | Buy |
Journey Medical Corp Stock (DERM) Latest News
Journey gets FDA okay for Emrosi, releases preliminary Q3 earnings report (NASDAQ:DERM) - Seeking Alpha
US FDA approves Journey Medical's drug for long-term skin condition - Reuters
Journey Medical gains as US FDA approves skin condition drug - XM
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - Yahoo Finance
mWell says users gain access to 26 MPH hospitals - BusinessWorld Online
Seven PDUFA dates on FDA’s November calendar - BioCentury
Nahdi continues the growth journey with 9.0% yoy revenue increase and meeting the profitabilty guidance - ZAWYA
Biotech Stocks Facing FDA Decision In November 2024 - RTTNews
Journey Medical Co. (NASDAQ:DERM) Short Interest Update - MarketBeat
Pixee Medical Inc. Announces Josh Hagel Appointed Vice President of Sales, US - OrthoSpineNews
The Nugget Trap (RWA) Token Offering NGTG$$ commences trading - ForexTV.com
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - The Manila Times
Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com
GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view - Yahoo Finance
Live Webinar | Overcoming SASE Adoption Journey Challenges for USA Inc. - BankInfoSecurity.com
SWK Holdings Provides Portfolio Update - AccessWire
Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality - The Manila Times
Will It Be A Smooth Sailing For Journey Medical's Rosacea Drug At The FDA? - RTTNews
Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest - MarketBeat
Best travel insurance companies of October 2024 - USA TODAY
GE HealthCare - linkedin
Microsoft expands AI capabilities to shape a healthier future - Microsoft
Baird Medical Lists in the U.S. on the Nasdaq Exchange - Yahoo Finance
SWK Holdings announces board member resignation - Investing.com
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - Yahoo Finance
ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City - The Manila Times
PVG Asset Management Corp Purchases New Holdings in Journey Medical Co. (NASDAQ:DERM) - Defense World
Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns? - Yahoo Finance
Quantum Health Appoints Fares Alraie as Chief Technology Officer to Enhance Company’s Generative AI Platform, Operational Scale and Member Journey Mapping Technology - Yahoo Finance
WebMD Announces 2024 Health Heroes: Visionaries Leveraging AI in Medicine - The Malaysian Reserve
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
Leading where medicine is going - Johnson & Johnson
Transforming Traditions: A Journey from Traditional Trade to E-commerce Success with Alibaba.com - Alibaba
Alight expands Partner Network with the additions of Journey and Carrot Fertility - Yahoo Finance
Critical Survey: Syndax Pharmaceuticals (NASDAQ:SNDX) vs. Journey Medical (NASDAQ:DERM) - Defense World
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements - StockTitan
Pfizer Advances On Its Cancer Journey - Yahoo Finance
Cisco: A Journey of Resilience and New Beginnings - Yahoo Finance
Reflecting on Tran Thi Yen Phi's Journey with Alibaba.com: A Success Story of Global E-commerce - Alibaba
From Captivity to Care: The Journey Through BAMC - San Antonio Magazine
Litmos Expands AI Product Portfolio to Enhance the Corporate Learning Journey - Yahoo Finance
Ultimate Medical Academy Celebrates Academic Journey for Thousands of Graduates at September Commencement - Yahoo Finance
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference - Yahoo Finance
Lake Street Capital Initiates Coverage on Journey Medical (NASDAQ:DERM) - Defense World
Lake Street starts Journey Medical with Buy, sets stock target on product launch - Investing.com
Journey Medical (NASDAQ:DERM) Receives New Coverage from Analysts at Lake Street Capital - MarketBeat
ZEISS Leads IMTS Visitors on a Journey to Discover their Superforce - Yahoo Finance
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Cambridge Investment Research Advisors Inc. Makes New Investment in Journey Medical Co. (NASDAQ:DERM) - MarketBeat
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Journey Medical Corp Stock (DERM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):